Showing 1 - 10 of 104
Whereas much literature exists on “choice overload,” little is known about effects of numbers of alternatives in donation decisions. How do these affect both the size and distribution of donations? We hypothesize that donations are affected by the reputation of recipients and increase with...
Persistent link: https://www.econbiz.de/10008727819
We study the impact of university-industry research collaborations on academic output, in terms of productivity and direction of research. We report findings from a longitudinal dataset on all the researchers from the engineering departments in the UK in the last 20 years. We control for the...
Persistent link: https://www.econbiz.de/10008564761
This paper studies oligopolistic competition in off-patent pharmaceutical markets using a vertical product differentiation model. This model can explain the observation that countries with stronger regulations have smaller generic market shares. It can also explain the differences in observed...
Persistent link: https://www.econbiz.de/10005827428
The trade-off between property rights/price regulation and innovation depends on country characteristics and drug industry specificities. Access to drugs and innovation can be reconciled by seven ways that, among others, include: public health strengthening in the countries with the largest...
Persistent link: https://www.econbiz.de/10005827430
This article analyses the impact of the reference price system on the price-setting strategies of the pharmaceutical firms and on the level of generic usage. This model is the first to take explicitly into account the impact of the reference price mechanism on the level of competition between...
Persistent link: https://www.econbiz.de/10005827432
This paper analyses the application of hybrid risk adjustment versus either prospective or concurrent risk adjustment formulae in the context of funding pharmaceutical benefits for the population of an integrated healthcare delivery organization in Catalonia during years 2002 and 2003. We apply...
Persistent link: https://www.econbiz.de/10005827433
The trade-off between property rights/price regulation and innovation depends on country characteristics and drug industry specificities. Access to drugs and innovation can be reconciled by seven ways that, among others, include: public health strengthening in the countries with the largest...
Persistent link: https://www.econbiz.de/10005827524
The organisation of inpatient care provision has undergone significant reform in many southern European countries. Overall across Europe, public management is moving towards the introduction of more flexibility and autonomy . In this setting, the promotion of the further decentralisation of...
Persistent link: https://www.econbiz.de/10005827530
Many governments in developing countries implement programs that aim to address nutrional failures in early childhood, yet evidence on the effectiveness of these interventions is scant. This paper evaluates the impact of a conditional food supplementation program on child mortality in Ecuador....
Persistent link: https://www.econbiz.de/10009650739
This paper provides empirical evidence on the explanatory factors affecting introductory prices of new pharmaceuticals in a heavily regulated and highly subsidized market. We collect a data set consisting of all new chemical entities launched in Spain between 1997 and 2005, and model launching...
Persistent link: https://www.econbiz.de/10010553343